Considering the mechanism by which induction of endogenous HO-1 expression can confer anti-inflammatory effects in intestinal inflammation, the pharmacological application of HO-1 end-products, particularly CO, can mimic the HO-1-dependent anti-inflammatory action. The gene discussed is HMOX1; the disease is gastroenteritis.